cephalosporin c has been researched along with Neonatal Sepsis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 14 (93.33) | 2.80 |
| Authors | Studies |
|---|---|
| Akselsen, AB; Sheth, CC; Veses, V | 1 |
| Benhammou, V; Boileau, P; Charlier, C; Foix L'Helias, L; Gras-Le Guen, C; Kayem, G; Letouzey, M; Lorthe, E; Torchin, H | 1 |
| Darlow, CA; Hope, W | 2 |
| Da Costa, RMA; Darlow, CA; Das, S; Ellis, S; Farrington, N; Franceschi, F; Hope, W; Jimenez-Valverde, A; Johnson, A; Kolamunnage-Dona, R; McEntee, L; Neely, M; Piddock, LJV; Sharland, M; Unsworth, J | 1 |
| Standing, JF | 1 |
| Da Costa, RMA; Darlow, CA; Das, S; Ellis, S; Farrington, N; Franceschi, F; Hope, W; Jagota, B; Jimenez-Valverde, A; Johnson, A; Kolamunnage-Dona, R; McEntee, L; Neely, M; Piddock, L; Sharland, M; Unsworth, J | 1 |
| Chen, PY; Dong, QY; Gong, XY; He, XR; Hu, JT; Li, W; Wang, T; Yang, YH; Yu, YQ | 1 |
| Barchia, I; Karmila, A; Ramandati, A; Zhang, L | 1 |
| Bradley, JS; Chan, PLS; Hammond, J; Hendrick, VM; Leister-Tebbe, HK; Mas Casullo, V; Raber, SR; Riccobene, T; Stone, GG; Yan, JL | 1 |
| Chen, X; Guo, S; Liu, D; Zhong, M | 1 |
| Dissaneevate, S; Janjindamai, W; Maneenil, G; Premprat, N; Thatrimontrichai, A | 1 |
| Chimhini, G; Chimhuya, S; Chisenga, M; De, S; Ferreyra, C; Fitzgerald, F; Kranzer, K; Malou, N; Mujuru, HA; Olaru, ID; Piton, J; Yeung, S | 1 |
| Abayneh, M; Akeju, O; Ambachew, R; Bekele, D; Carvalho, MJ; Chan, GJ; Gebreyohannes, Z; Goddard, FGB; Metaferia, G; Milton, R; Odumade, OA; Sands, K; Solomon, S; Thomson, K; Van Wickle, K; Walsh, TR | 1 |
| Cazanave, C; Charlier, C; Doret Dion, M | 1 |
1 review(s) available for cephalosporin c and Neonatal Sepsis
| Article | Year |
|---|---|
Efficacy of empiric antibiotic treatment of late-onset neonatal sepsis caused by Enterobacteriaceae: A systematic review.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Escherichia coli; Gentamicins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis; Sepsis | 2022 |
1 trial(s) available for cephalosporin c and Neonatal Sepsis
| Article | Year |
|---|---|
Phase 2 Study of the Safety, Pharmacokinetics and Efficacy of Ceftaroline Fosamil in Neonates and Very Young Infants With Late-onset Sepsis.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Double-Blind Method; Female; Humans; Infant; Infant, Newborn; Internationality; Male; Neonatal Sepsis | 2020 |
13 other study(ies) available for cephalosporin c and Neonatal Sepsis
| Article | Year |
|---|---|
Antibiotic prophylaxis in preterm premature rupture of membranes at 24-31 weeks' gestation: Perinatal and 2-year outcomes in the EPIPAGE-2 cohort.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cephalosporins; Cohort Studies; Escherichia coli; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature; Macrolides; Neonatal Sepsis; Pregnancy; Pregnancy Outcome; Premature Birth; Prospective Studies | 2022 |
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis | 2022 |
Flomoxef and fosfomycin in combination for the treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistance.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Fosfomycin; Humans; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis | 2022 |
Comment on: Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Humans; Infant, Newborn; Klebsiella Infections; Neonatal Sepsis | 2022 |
Flomoxef for neonates: extending options for treatment of neonatal sepsis caused by ESBL-producing Enterobacterales-authors' response.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Humans; Infant, Newborn; Klebsiella Infections; Neonatal Sepsis | 2022 |
Assessment of flomoxef combined with amikacin in a hollow-fibre infection model for the treatment of neonatal sepsis in low- and middle-income healthcare settings.
Topics: Amikacin; Anti-Bacterial Agents; Cephalosporins; Delivery of Health Care; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Neonatal Sepsis | 2022 |
[A 10-year retrospective study of pathogens and antimicrobial resistance in neonatal sepsis].
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Humans; Infant; Infant, Newborn; Infant, Premature; Microbial Sensitivity Tests; Neonatal Sepsis; Penicillins; Retrospective Studies; Sepsis | 2022 |
Clinical and bacteriological profile of culture-negative and culture-proven neonatal sepsis in Palembang, Indonesia.
Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporins; Humans; Indonesia; Infant, Newborn; Neonatal Sepsis; Sepsis | 2022 |
Neonatal septicemia caused by a rare pathogen: Raoultella planticola - a report of four cases.
Topics: Anti-Bacterial Agents; Birth Weight; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gestational Age; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Piperacillin | 2020 |
Risks and burdens of third-generation cephalosporin resistant Enterobacteriaceae in neonatal sepsis.
Topics: Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospital Mortality; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Neonatal Sepsis; Retrospective Studies; Risk Factors; Thailand | 2020 |
Evaluation of a Novel Culture System for Rapid Pathogen Identification and Detection of Cephalosporin Resistance in Neonatal Gram-negative Sepsis at a Tertiary Referral Unit in Harare, Zimbabwe.
Topics: Adult; Bacterial Load; Blood Culture; Cephalosporin Resistance; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Male; Microbiological Techniques; Mothers; Neonatal Sepsis; Zimbabwe | 2021 |
Prevalence and risk factors for antimicrobial resistance among newborns with gram-negative sepsis.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ethiopia; Female; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Male; Microbial Viability; Neonatal Sepsis; Penicillin G; Pregnancy; Prevalence; Tertiary Care Centers | 2021 |
[Antibiotic prophylaxis in preterm premature rupture of membranes: CNGOF preterm premature rupture of membranes guidelines].
Topics: Amoxicillin; Antibiotic Prophylaxis; Cephalosporins; Erythromycin; Escherichia coli; Escherichia coli Infections; Female; Fetal Membranes, Premature Rupture; France; Humans; Infant, Newborn; Neonatal Sepsis; Pregnancy; Premature Birth; Streptococcal Infections; Streptococcus agalactiae | 2018 |